Previously characterized by uneven performance, the market for gastrointestinal remedies posted a 4% increase since 2003--the largest year-on-year increase since 1999. The market owes much of its recent prosperity to Procter & Gamble’s Prilosec, which became available over the counter in 2003. Sales of this proton pump inhibitor reached nearly $150 million in its first full year on the over-the-counter market. Over-the-counter availability, however, can also prove challenging for the market, as private-label manufacturers take advantage of patent expirations to develop comparable, less expensive products.

Fortunately, demographic shifts are providing new opportunities for makers of gastrointestinal remedies. The number of adults over 45 is set to increase significantly between 2004 and 2009, creating a market of well-informed consumers who are proactive in self-diagnosis, treatment and prevention. Understanding and targeting this market will be critical to the success of drug manufacturers.

Mintel’s new report on the gastrointestinal remedies market provides important, up-to-date information about your consumers. After analyzing the incidence of gastrointestinal ailments, Mintel delves into the attitudes and behaviors affecting purchasing decisions. Who is using gastrointestinal remedies most frequently? What distinct preferences exist by race and ethnicity regarding types of stomach remedies? Who keeps remedies on hand, and who will use them only as a last resort?

Mintel answers these questions and more while providing an intensive analysis of the entire gastrointestinal remedies market. Market drivers, size, trends, segmentation, and distribution are all explored in depth. A five-year market forecast helps you prepare for changes ahead.

This report covers over-the-counter remedies for all types of heartburn, indigestion, diarrhea, motion sickness, and nausea.

Excluded are lactose intolerance medications, home remedies, enemas, and herbal or homeopathic cures.